Table 4.
Variable | Total population (n = 120) |
---|---|
ACE‐I, % of target dose | 59 ± 29 |
ARB, % of target dose | 49 ± 29 |
Beta‐blocker, % of target dose | 54 ± 25 |
Spironolactone, mg | 25 (25–25) |
Loop diuretic, mg furosemide equivalents | 40 (20–40) |
ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker.